Matthew Pink
Company: Biodesix
Job title: Vice President - Business Development
Seminars:
How a Simple Blood Draw & Multi-Omic Testing Can Optimize Cancer Treatment Strategies 11:05 am
ddPCR™ testing drives progress in early cancer diagnosis, personalized therapy, and molecular residual disease detection Proteomic testing can identify a patient’s immune response to cancer; identifying those patients with an aggressive disease state that may benefit from enhanced surveillance, immunotherapy combinations or chemotherapyRead more
day: Day Three Track A